Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AbCellera Biologics Stock Jumped 19.4% Last Month


Shares of AbCellera Biologics (NASDAQ: ABCL) gained 19.4% in September, according to data from S&P Global Market Intelligence. The stock jumped in the middle of the month after the biotech company announced that it had formed a new partnership with Moderna and continued to climb after it detailed another new partnership with Everest Medicines.

ABCL Chart

ABCL data by YCharts

Continue reading


Source Fool.com

Like: 0
Share

Comments